Assessment of the Molecular Diagnostic Market for Adenovirus NA Tests in France

dii is an international marketing consulting company entirely specialised in healthcare markets providing market information and support to strategic market decisions. In cooperation with key industry a Continuous European Molecular Market Assessment has been realized in 2009 with the 2 main objectives:
1) Classification of laboratories by ownership, size and overall NA test volume
2) Market assessment for 44 NA tests on volumes, trends, kits and analyzers. All data is presented in Excel and PPT. Excel addresses all quantitative questions at segment level, including all volume projection scenarios and statsitical detail, PPT presents the key data and provides an interpretation of general business implications

Report Highlights

[Studien Infos ausblenden]

Total number of clinical diagnostic labs by lab type: small, medium and large hospitals, non hospital (private) labs
Number of clinical diagnostic NA labs by lab type: small, medium and large hospitals, non hospital (private) labs, and by NA test volume: >/< 20 NA tests per day
# of lab performing test by test types (Adenovirus, BK, C. Diff, CF, CMV, CMV Viral, CT, CT/NG, EBV, EBV Viral, Enterovirus, Factor II, Factor V Leiden, Fragile X, GAS, GBS, HBV qual, HBV resistance, HBV Viral Load, HCV Genotyping, HCV qual, HCV Viral Load, Her2Neu, HIV Genotyping, HIV qual, HIV Viral Load, HLA Typing, HPV, HPV Genotyping, HSV 1, HSV 2, Human Metapneumovirus, Influenza A, B, MAC (formerly MAI), MRSA, MSSA, MTB, MTD (Tuberculosis), NG, Parainfluenza 1,2,3, RSV, Staphylococcus aureus, VRE, VZV, Warfarin sensitivity (CYP2C9, VKOR1))
Total # of test/results per test type & growth rate (Adenovirus, BK, C. Diff, CF, CMV, CMV Viral, CT, CT/NG, EBV, EBV Viral, Enterovirus, Factor II, Factor V Leiden, Fragile X, GAS, GBS, HBV qual, HBV resistance, HBV Viral Load, HCV Genotyping, HCV qual, HCV Viral Load, Her2Neu, HIV Genotyping, HIV qual, HIV Viral Load, HLA Typing, HPV, HPV Genotyping, HSV 1, HSV 2, Human Metapneumovirus, Influenza A, B, MAC (formerly MAI), MRSA, MSSA, MTB, MTD (Tuberculosis), NG, Parainfluenza 1,2,3, RSV, Staphylococcus aureus, VRE, VZV, Warfarin sensitivity (CYP2C9, VKOR1))
Market share: # of tests/results by supplier (Roche Diagnostics, Innogenetics, Abbott, Bio-Rad, bioMérieux, Stratagene, Applied Biosystems, Qiagen, Siemens, Cepheid, Digene)
Installed base of analyzers
Trends
[Inhaltsverzeichnis ausblenden]